Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever

被引：60

作者：

Alpay, Nilufer ^{[1
]}

Sumnu, Abdullah ^{[1
]}

Caliskan, Yasar ^{[2
]}

Yazici, Halil ^{[2
]}

Turkmen, Aydin ^{[2
]}

Gul, Ahmet ^{[3
]}

机构：

[1] Istanbul Univ, Istanbul Sch Med, Dept Internal Med, Istanbul, Turkey

[2] Istanbul Univ, Istanbul Sch Med, Div Nephrol, Istanbul, Turkey

[3] Istanbul Univ, Istanbul Sch Med, Div Rheumatol, Istanbul, Turkey

来源：

RHEUMATOLOGY INTERNATIONAL | 2012年 / 32卷 / 10期

关键词：

Familial Mediterranean fever; Anakinra; Renal transplantation; Amyloidosis;

D O I：

10.1007/s00296-010-1474-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Familial Mediterranean fever (FMF) is an autosomal recessive disease characterized by self-limited recurrent attacks of fever and serositis. The serious complication of FMF is AA-type amyloidosis, which can result in end-stage renal disease. Although colchicine is effective in the majority of patients, there is no established treatment for those who are resistant or intolerant to colchicine. We herein report the efficacy of anakinra in a 52-year-old Turkish patient with FMF, secondary amyloidosis and renal transplant, who was resistant to colchicine treatment.

引用

页码：3277 / 3279

页数：3

共 10 条

[1] The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever [J].

Calligaris, Lorenzo ;

Marchetti, Federico ;

Tommasini, Alberto ;

Ventura, Alessandro .

EUROPEAN JOURNAL OF PEDIATRICS, 2008, 167 (06) :695-696

[2] The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1β production [J].

Chae, Jae Jin ;

Wood, Geryl ;

Masters, Seth L. ;

Richard, Katharina ;

Park, Grace ;

Smith, Brian J. ;

Kastner, Daniel L. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (26) :9982-9987

[3] Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate - Results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial [J].

Cohen, S ;

Hurd, E ;

Cush, J ;

Schiff, M ;

Weinblatt, ME ;

Moreland, LW ;

Kremer, J ;

Bear, MB ;

Rich, WJ ;

McCabe, D .

ARTHRITIS AND RHEUMATISM, 2002, 46 (03) :614-624

[4] Effective treatment of a colchicine-resistant familial Mediterranean fever patient with anakinra [J].

Kuijk, Loes M. ;

Govers, Anita M. A. P. ;

Hofhuis, Willem J. D. ;

Frenkel, Joost .

ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (11) :1545-1546

[5] Colchicine nonresponsiveness in familial Mediterranean fever: Clinical, genetic, pharmacokinetic, and socioeconomic characterization [J].

Lidar, M ;

Scherrmann, JM ;

Shinar, Y ;

Chetrit, A ;

Niel, E ;

Gershoni-Baruch, R ;

Langevitz, P ;

Livneh, A .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2004, 33 (04) :273-282

[6] COLCHICINE PREVENTS KIDNEY-TRANSPLANT AMYLOIDOSIS IN FAMILIAL MEDITERRANEAN FEVER [J].

LIVNEH, A ;

ZEMER, D ;

SIEGAL, B ;

LAOR, A ;

SOHAR, E ;

PRAS, M .

NEPHRON, 1992, 60 (04) :418-422

[7] Familial Mediterranean fever successfully treated with etanercept [J].

Mor, Adam ;

Pillinger, Michael H. ;

Kishimoto, Mitsumasa ;

Abeles, Aryeh M. ;

Livneh, Avi .

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2007, 13 (01) :38-40

[8] Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation [J].

Moser, Christian ;

Pohl, Gudrun ;

Haslinger, Isabella ;

Knapp, Sylvia ;

Rowczenio, Dorota ;

Russel, Tonia ;

Lachmann, Helen J. ;

Lang, Ursula ;

Kovarik, Josef .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (02) :676-678

[9] The spectrum of Familial Mediterranean Fever (FMF) mutations [J].

Touitou, I .

EUROPEAN JOURNAL OF HUMAN GENETICS, 2001, 9 (07) :473-483

[10]

Tunca M, 2004, CLIN EXP RHEUMATOL, V22, pS37

← 1 →